EN
Home/Answers/Rash and itching
ALLAll countries Side effects and safety

Can tirzepatide or semaglutide cause a rash or itching?

What we checked16 sources, each one opened and linked to the sentence it supportsLast checked Nov 16, 2026 · Next review due Nov 16, 2027 · How we write
The short answer

Yes. Labels for tirzepatide (Mounjaro, Zepbound) and semaglutide (Ozempic, Wegovy) list allergic skin reactions such as rash, itching and hives. In tirzepatide weight-management trials reported in the UK Mounjaro product information, 5.0% had an allergic reaction, against 3.8% on placebo. Rarely, swelling of the face or throat or trouble breathing signals a severe reaction.

How common are rash and itching on these medicines?

Allergic skin reactions are a listed side effect of both medicines, and in trials they were a little more frequent than on placebo (dummy injections).12

In the UK Mounjaro product information, allergic reactions such as hives, eczema and rash affected 5.0% of people in tirzepatide weight-management trials, against 3.8% on placebo.2 In diabetes trials the figures were 3.2% and 1.7%.2 The EU product information gives the same figures.8

The US Zepbound label splits reactions by timing. Reactions within one day of a dose affected 2.1% of people, against 0.4% on placebo, and later ones affected 3.5%, against 2.7%.1 Most were skin reactions such as rash and itching.1

The UK Mounjaro leaflet lists allergic rash, itching and eczema as common, meaning up to 1 in 10 people.3 The UK Ozempic leaflet lists rash, itching or hives as uncommon, up to 1 in 100.4 The US Wegovy and Ozempic labels list rash and hives among reports made after approval.56 These figures come from separate trials, so they cannot rank the medicines.

Is it an injection site reaction or something wider?

Labels count redness and itching where you inject separately from allergic reactions elsewhere on the body, and most site reactions in tirzepatide trials were mild.12

The US Zepbound label counts redness, itching, pain and rash at the injection site as site reactions.1 In the UK Mounjaro product information, redness and itching were the most common site signs, and 91% of site reactions were mild.2 Our answer on injection site reactions covers these in more detail.

In the US Zepbound trials, allergic reactions were more frequent in people whose bodies made antibodies against tirzepatide: 6.2%, against 3% in those who did not.1 The UK Mounjaro KwikPen leaflet says the pen contains benzyl alcohol, a preservative that may cause allergic reactions.3

When is a rash a sign of a serious reaction?

Severe allergic reactions are rare, but the US and UK documents we opened all list anaphylaxis (a severe whole-body allergy) and angioedema (swelling under the skin).134567

In two US Zepbound weight-loss trials, 0.1% of people had a severe allergic reaction, against none on placebo.1 UK leaflets for Mounjaro, Wegovy and Ozempic list severe allergic reactions as rare, up to 1 in 1,000 people.374 The EU Wegovy product information also lists anaphylactic reactions.9

The US Zepbound, Wegovy and Ozempic labels say to stop the medicine if an allergic reaction occurs.156 They also say not to use it after a serious allergic reaction to the medicine or its ingredients.156

These labels advise caution for anyone who had anaphylaxis or angioedema with another GLP-1 medicine. They say it is unknown whether such people are more likely to react.156

Itching can also have causes unrelated to the medicine. The NHS says it can less commonly be a sign of thyroid, liver or kidney problems.15

What do people on GLP-1 medicines report about rash and itching?

From public patient forums: 34 Reddit threads in r/Zepbound, r/Mounjaro, r/mounjarouk, r/Ozempic, r/Wegovy and r/Semaglutide, read October 2025 to October 2026. Personal reports, not medical evidence.

What people describe

  • Matches the label Many describe a rash or hives away from the injection site, on the trunk, limbs or whole body. UK leaflets list allergic rash, itching and hives among side effects.34
  • Not studied Many say a rash began in the first weeks, and many say it began after months without problems. Many link it to a dose increase, a switch between medicines or a restart. We found single case reports, but no study of when these rashes usually start.
  • Not studied Many describe itching with no visible rash. We found no trial figure for itch without a rash on these medicines.
  • Matches the label Several describe throat itching, facial swelling or an emergency visit. The US Zepbound label lists anaphylaxis and angioedema among reports made after approval.1

Advice people share

  • Matches the NHS Many look for other causes first, such as a new detergent or soap, food, heat, stress or pollen. The NHS lists foods, chemicals, heat and medicines among the triggers for hives.14
  • Matches the NHS Many say oral antihistamines eased the itch, though several found little or short-lived relief. The NHS says a pharmacist can advise on antihistamines for hives.14 Its cetirizine page lists people who should check first, including those with kidney failure or epilepsy.16
  • Matches the label Many advise asking the prescriber before the next dose. The US Zepbound label says to stop the medicine and get medical attention promptly if an allergic reaction occurs.1
  • Label says otherwise Posts also urge carrying on through a spreading whole-body reaction or after throat itching. The US labels say not to use these medicines after a serious allergic reaction to them.15

In your country

The US, UK, EU, Australian and Canadian documents we opened all list allergic skin reactions and rare severe reactions; only the trial pools and wording differ.128101112

Australia

Sold as: Tirzepatide: Mounjaro. Semaglutide injection, weight: Wegovy. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: none (Wegovy pill treated as not approved). Semaglutide tablets, diabetes: Rybelsus approved; whether supplied not confirmed.

Label: The answer above applies.

Emergency number: 000

Side effects and risks in Australia

Canada

Sold as: Tirzepatide: Mounjaro, Mounjaro KwikPen, Zepbound. Semaglutide injection, weight: Wegovy. Semaglutide injection, diabetes: Ozempic; Semaglutide Injection (Dr. Reddy’s; shortage reported Jul 2026, lots recalled Aug 2026); Apo-Semaglutide (one lot recalled Aug 2026). Semaglutide tablets, weight: none (no oral Wegovy in Health Canada’s drug database). Semaglutide tablets, diabetes: Rybelsus. Semaglutide approved but not marketed: Sevmia, Poviztra, Plosbrio, Aspen-Semaglutide, Semaglutide Injection (Aspen), Sandoz Semaglutide.

Label: The answer above applies.

Emergency number: 911

Side effects and risks in Canada

France

Sold as: Tirzepatide: Mounjaro. Semaglutide injection, weight: Wegovy. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: none (Wegovy pill not sold in France). Semaglutide tablets, diabetes: none found (Rybelsus not in France’s medicines database).

Label: The answer above applies.

Emergency number: 15 or 112

Side effects and risks in France (in French)

Germany

Sold as: Tirzepatide: Mounjaro. Semaglutide injection, weight: Wegovy, including 7.2 mg. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: Wegovy Tablette. Semaglutide tablets, diabetes: Rybelsus.

Label: The answer above applies.

Emergency number: 112

Side effects and risks in Germany (in German)

India

Sold as: Tirzepatide: Mounjaro, Yurpeak. Semaglutide injection, weight: Wegovy; Poviztra; Noveltreat. Semaglutide injection, diabetes: Ozempic; Obeda (Dr Reddy’s; recalled Jul 2026 over an active-ingredient impurity; on 23 Oct 2026 the company said it planned to relaunch in Nov; resumption not confirmed at 8 Nov 2026; distributors told Reuters it may be discontinued); Sematrinity; GLIPIQ; Semalix (batches recalled Jul 2026); Semanat; Semafull. Semaglutide injection, diabetes and weight: Semaglyn; Mashema; Alterme; Semasize; Obesema; Hepaglide. Semaglutide, diabetes and weight (form not confirmed): Obeda Pro; Obeda Plus (Dr Reddy’s, made by Hetero Labs; in the market from late Jul 2026). Semaglutide injection, use not confirmed: Semanext; Livarise; Sundae. Semaglutide, form and use not confirmed: Samakind; Usema (batches recalled). Semaglutide tablets, weight: not confirmed. Semaglutide tablets, diabetes: Rybelsus; Sembolic; Obeda (tablets not part of the Jul 2026 recall).

Label: We did not open an Indian label for this page, so this answer relies on the US, UK and EU labels.

Emergency number: 112

Side effects and risks in India

Saudi Arabia

Sold as: Tirzepatide: Mounjaro, Mounjaro KwikPen. Semaglutide injection, weight: Wegovy. Semaglutide injection, diabetes: Ozempic; Tasylev; Lugyda; Glucentra. Semaglutide tablets, weight: none (Wegovy pill not registered). Semaglutide tablets, diabetes: Rybelsus.

Label: We did not open a Saudi label for this page, so this answer relies on the US, UK and EU labels.

Emergency number: 997 or 911

Side effects and risks in Saudi Arabia (in Arabic)

United Arab Emirates

Sold as: Tirzepatide: Mounjaro. Semaglutide injection, weight: Wegovy. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: Wegovy pill. Semaglutide tablets, diabetes: Rybelsus.

Label: We did not open a UAE label for this page, so this answer relies on the US, UK and EU labels.

Emergency number: 998 for an ambulance, or 999

Side effects and risks in the UAE

United Kingdom

Sold as: Tirzepatide: Mounjaro. Semaglutide injection, weight: Wegovy, including 7.2 mg. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: Wegovy tablets (authorised 11 Jun 2026; retail sale not confirmed). Semaglutide tablets, diabetes: Rybelsus.

Label: The answer above applies.

Emergency number: 999

Side effects and risks in the UK

United States

Sold as: Tirzepatide: Zepbound, Mounjaro. Semaglutide injection, weight: Wegovy, including Wegovy HD 7.2 mg. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: Wegovy pill. Semaglutide tablets, diabetes: Ozempic tablets; Rybelsus (being discontinued).

Label: The answer above applies.

Emergency number: 911

Side effects and risks in the US

Get help now: call your local emergency number Trouble breathing, wheezing, swelling of the face, tongue or throat, large welts or hives, a weak and rapid pulse, dizziness or fainting can signal anaphylaxis, a severe allergic reaction.13 Emergency numbers: 911 in the US and Canada, 999 in the UK, 998 or 999 in the UAE, 000 in Australia, 112 in India and Germany, 15 or 112 in France, 997 or 911 in Saudi Arabia.

Contact your prescriber or a doctor right away if you get a severe rash or severe itching. The US Zepbound and Wegovy Medication Guides list these among signs of a serious allergic reaction and say to stop the medicine and get medical help right away.15

The NHS advises an urgent GP appointment, or NHS 111 in the UK, if hives spread, keep coming back, do not improve after 2 days, or come with a high temperature and feeling unwell.14

Read the full picture

Related questions

Did this answer your question?

Sources

  1. Eli Lilly. Zepbound (tirzepatide) US prescribing information and Medication Guide.
  2. Eli Lilly. Mounjaro KwikPen UK Summary of Product Characteristics, emc.
  3. Eli Lilly. Mounjaro KwikPen UK patient leaflet, emc.
  4. Novo Nordisk. Ozempic 1 mg UK patient leaflet, emc.
  5. Novo Nordisk. Wegovy (semaglutide) US label and Medication Guide, on DailyMed.
  6. Novo Nordisk. Ozempic (semaglutide) US label, on DailyMed.
  7. Novo Nordisk. Wegovy 0.5 mg FlexTouch UK patient leaflet, emc.
  8. European Medicines Agency. Mounjaro EU product information.
  9. European Medicines Agency. Wegovy EU product information.
  10. Eli Lilly Australia. Mounjaro Australian Product Information, version A14.0, October 2026.
  11. Novo Nordisk Australia. Wegovy Australian Product Information.
  12. Eli Lilly Canada. Zepbound Canadian Product Monograph.
  13. American College of Emergency Physicians. Allergies and Anaphylaxis: Know When to Go to the ER.
  14. NHS. Hives, last reviewed 26 April 2024.
  15. NHS. Itchy skin, last reviewed 19 July 2023.
  16. NHS. Who can and cannot take cetirizine.

Last checked Nov 16, 2026 · Next review due Nov 16, 2027 · Report an error

How this answer was made. Written by the GLP Guidebook team from the sources above, all checked on Nov 9 or Nov 16, 2026. The “What people report” section summarises public patient forum posts we read; it is not medical evidence, and we never pass on advice that goes against the label. It’s general information, not medical advice. Talk to a doctor, pharmacist or other licensed prescriber before starting, stopping or changing any medicine. In an emergency, call your local emergency number. How we write